# US 2006/0154325 A1 · Synthesis of epoxide based inhibitors of cysteine proteases

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0154325 A1
- Document ID: US20060154325A1
- Status: Published application
- Kind: A1
- Application number: 11/329,818
- Filed: 2006-01-10
- Published: 2006-07-13
- Earliest claimed: 2005-01-10
- Inventors: Matthew Bogyo; Steven Verhelst
- Web page: https://patentgrep.com/patent/US20060154325A1

## CPC

- C07K 1/04: on carriers {(C07K1/003, C07K1/006 take precedence)}
- C07D 303/08: with hydrocarbon radicals, substituted by halogen atoms, nitro radicals or nitroso radicals
- C07D 303/48: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. ester or nitrile radicals
- C07K 5/0205: {containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof}
- C07K 5/06026: {the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala}
- C07K 5/06034: {the side chain containing 2 to 4 carbon atoms}
- C07K 5/06078: {and aromatic or cycloaliphatic}
- C07K 7/02: Linear peptides containing at least one abnormal peptide link
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

Epoxide based cysteine protease inhibitors containing peptide derivatives and methods for synthesizing them in sold phase are disclosed. Preferably, an epoxy succinyl “warhead” (for binding to the enzyme) is prepared, having two amino acid residues or residue-like structures on either side. Natural and non-natural amino acids may be used. The present process may be carried out entirely on a solid support, with the proviso that a dipeptide like group is prepared prior to coupling to one side of the supported complex. The method lends itself to more efficient inhibitor synthesis, and may be employed with mixtures of peptide compounds, and various modifications of epoxides to create diverse libraries of inhibitors.

## Claims

### Claim 1

A method for synthesizing an epoxide peptide derivative, comprising:
(a) immobilizing a first peptide derivative to a solid support, whereby the first peptide derivative has a free amino group bound to a protective group;
(b) deprotecting the amino group of the immobilized compound of step (a);
(c) coupling the compound of step (b) to an diester epoxide to form an amide bond with the compound of step (b) to obtain an immobilized ester epoxide—first peptide derivative;
(d) converting the immobilized ester epoxide of step (c) to a free acid and coupling a second peptide derivative to the free acid on the support; and
(e) releasing the compound of step (d) from the solid support to yield an epoxide having two peptide derivatives attached thereto.

### Claim 2 (depends on 1)

The method of claim 1 wherein the first and second peptide derivatives each comprise a peptoid.

### Claim 3 (depends on 1)

The method of claim 1 wherein the epoxide having two peptide derivatives attached thereto of step (e) has a formula according to a compound selected from the group consisting of COMPOUND1, COMPOUND2, or COMPOUND 3, wherein AA1, AA2, R1, and R2 are amino acid side chains selected from naturally occurring amino acids, * is between 0 and 10, L1 is NH or O, and R and R3 are peptide derivatives, and R4 is hydrogen or a lower alkyl diamide.

### Claim 4 (depends on 1)

The method of claim 1 wherein the two peptide derivatives each individually consist essentially of two amino acid derivatives.

### Claim 5 (depends on 1)

The method of claim 1 wherein the solid support comprises a PEG-based Rink resin.

### Claim 6 (depends on 1)

The method of claim 1 wherein the coupling of step (c) utilizes a reagent comprising nitrophenyl diester.

### Claim 7 (depends on 6)

The method of claim 6 wherein the nitrophenyl diester is of the formula of compound 4.

### Claim 8 (depends on 5)

The method of claim 5 wherein hydrolysis of the ester epoxide coupled to the first peptide is carried out in an alcohol solvent.

### Claim 9 (depends on 1)

The method of claim 1 wherein the first peptide derivative and the second peptide derivative are comprised in a mixture of different peptide derivatives, each attached to a solid support, for generating a plurality of different epoxy peptide derivatives.

### Claim 10

A method to synthesize epoxysuccinyl peptide derivatives, comprising:
(a) attaching a first amino acid derivative residue to a solid support;
(b) coupling a second amino acid derivative to the first amino acid derivative, while the first amino acid derivative is still on the solid support, to form a diamino acid complex;
(c) attaching an epoxy succinyl ester to an amine of the diamino acid complex on the solid support;
(d) hydrolyzing the epoxysuccinyl ester to form an epoxysuccinyl acid on the solid support; and
(e) eluting from the solid support the diamino acid-coupled dipeptide epoxysuccinyl acid.

### Claim 11 (depends on 10)

The method of claim 10 wherein step (c) comprises the step of: capping an N-terminus of the diamino acid complex with an epoxysuccinyl synthon using an activated nitrophenyl ester.

### Claim 12 (depends on 10)

The method of claim 10 wherein said solid support is a PEG-based Rink-resin.

### Claim 13 (depends on 10)

The method of claim 10 further comprising the use of alcohol as a solvent system during ester bond cleavage.

### Claim 14 (depends on 10)

The method of claim 10 further comprising the use of protected Fmoc-amino acid-amino acid—OtBu synthesized in solution as the dipeptide derivative of step (e).

### Claim 15 (depends on 14)

The method of claim 14 wherein the protected Fmoc-amino acid-amino acid—OtBu is deprotected prior to coupling to the free acid on solid support.

### Claim 16 (depends on 15)

The method of claim 15 further comprising the use of PyBOP as a coupling reagent for the dipeptide derivative of step (e).

### Claim 17 (depends on 10)

The method of claim 10 further comprising the step of attaching a peptide derivative to the epoxysuccinyl synthon acid on the solid support prior to the step of eluting from the solid support.

### Claim 18 (depends on 10)

The method of claim 10 wherein the first amino acid derivative and the second amino acid derivative are comprised in a mixture of different amino acid derivatives, each attached to a solid support, for generating a plurality of different epoxy peptide derivatives.

### Claim 19

A compound useful in synthesizing epoxysuccinyl-based cysteine protease inhibitors, of the formula:
where R is a lower straight or branched chain alkyl group having one to ten carbon atoms.

### Claim 20

An activity based probe for a protease of a formula selected from the group consisting of:
wherein AA1, AA2, R1 and R2 are each independently one of the twenty naturally occurring amino acid side chains; L1 is NH or O; R and R3 are each a peptide derivative having from one to three amino acid residues; the compound is in the form of either an R,R or an S,S enantiomer; R4 is H or a lower alkyl diamide, and * is a carbon linker of 0-4 carbon atoms.

### Claim 21 (depends on 20)

The compound of claim 20 wherein AA1 and AA2 are independently selected from: Gly, Thr, Ser, Trp, Tyr, Pro, His, Glu, Gln, Asp, Asn, Lys, and Arg.

### Claim 22 (depends on 20)

The compound of claim 20 where L1 is NH and R is a peptide having between 1 and three amino acid derivatives.

### Claim 23 (depends on 20)

A compound of claim 20 having the formula of COMPOUND 1, wherein R is between 1 and three amino acid residues selected from one of the twenty naturally occurring amino acids.
